Center for Aphasia Research and Treatment, Rehabilitation Institute of Chicago
Chicago, Illinois, 60611, United States
NCT Number: NCT01790880
The purpose of this study is to evaluate whether a computerized speech-language treatment delivered by a virtual therapist (Oral Reading for Language in Aphasia (ORLA) + Writing) results in improved written communication skills of study participants with aphasia (i.e., difficulty with the comprehension and expression of spoken and written language).
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Stroke is the third leading cause of death and the most common cause of disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. Approximately 150,000 to 250,000 stroke survivors becoming severely and permanently disabled each year. A common neurological deficit among stroke survivors, and thus a substantial contributor to post-stroke disability, is aphasia. The loss of, or difficulty with language is extremely debilitating.
Adequate written communication skills may be one of the barriers that has prevented individuals with aphasia from returning to work. Writing skills are also important for participation in social roles, such as household management, civic activities, or recreational activities with friends. Individuals with aphasia struggle to compose written documents such as personal letters, memos and reports. Furthermore, society's increased reliance on written forms of communication including email correspondence, instant messaging, texting, Twitter, and social networking sites such as Facebook, exacerbate the challenge that individuals with aphasia have in connecting with others, reestablishing and redefining their social roles and accomplishing their life-participation goals.
Computer-directed treatment offers a practical alternative to one-on-one traditional treatment provided by a clinician and may be a cost-effective way of extending therapy beyond the hospital and clinic to meet the needs of the growing numbers of individuals with chronic aphasia and to help them reintegrate into the community and workforce. This project evaluates the efficacy of a theoretically-motivated writing program that has been integrated with novel computer-based virtual therapy systems and that can be provided intensively to individuals with chronic aphasia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Practice on ORLA (Oral Reading for Language in Aphasia), a computer-based virtual therapy system.
Treatment includes writing of sentences in combination with ORLA
Time frame: Change from baseline to 6 weeks
Time frame: Change from baseline to 6 weeks
Time frame: Change from baseline to 6 weeks
Written responses on the Picture Description task of the Western Aphasia Battery-Revised and on a written picture-sequenced story retelling task will be scored for Correct Information Units
Time frame: Change from baseline to 6 weeks
Time frame: Change from baseline to 6 weeks
Time frame: Change from baseline to 6 weeks
Shirley Ryan AbilityLab
Other
Enhancing Written Communication in Persons With Aphasia: A Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01927302
Agrammatism, Agraphia
Chicago, Illinois, United States
View Trial DetailsNCT06891638
Aphasia, Brain Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT05570578
Aphasia, Brain Diseases
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT01540383
Aphasia, Behavior
Münster, North Rhine-Westfalia, Germany
View Trial Details